ArticleNpj viruses2026
Lassa virus circumvents macrophage and dendritic cell antiviral defences in its natural reservoir, the Natal multimammate mouse (Mastomys natalensis).
Article in Npj viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lassa Virus-A Persistent and Evolving Threat.Microorganisms · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Lassa virus (LASV) is a zoonotic arenavirus that causes severe hemorrhagic fever in humans but persists asymptomatically in its natural reservoir, the Natal multimammate mouse (Mastomys natalensis, NMM). The mechanisms underlying this disease tolerance remain poorly understood. Here, we establish and characterize macrophages (bmMΦs) and dendritic cells (bmDCs) derived from NMM bone marrow, and assess their response to LASV infection. Both cell types are permissive to LASV and remain viable throughout infection. However, LASV fails to induce transcriptional activation of antiviral or maturation-associated genes in either cell type, in stark contrast to the robust and stimulus-specific responses elicited by LPS, Poly I:C, and Sendai virus. A modest increase in CD80 surface expression was observed in LASV-infected DCs, uncoupled from transcriptional induction, suggesting post-transcriptional modulation. These data reveal a striking circumvention of innate immune activation in NMM myeloid cells despite productive LASV infection, supporting a model in which early immune evasion facilitates reservoir tolerance. This work provides mechanistic insight into LASV-host co-adaptation and establishes a functional in vitro system for dissecting immune responses in the natural reservoir.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.